Sign inJoin waitlistJoin the waitlist

Antoinette Tan

Physician · Atrium Health

Credentials: · · ·

History

Atrium Health
2019–Present

DREXEL UNIVERSITY
1999–2001
North Shore University Hospital - Northwell Health
1996–1999
Robert Wood Johnson Medical School
1992–1996

Research

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
Annals of Oncology · 2019 · 680 citations
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
Annals of Oncology · 2019 · 540 citations
Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma
PLoS ONE · 2014 · 414 citations

SS
Sandra Swain
18 papers
Mark Stein
9 papers
Arielle Heeke
7 papers
Hope Rugo
7 papers
JO
Joyce O'Shaughnessy
7 papers
RM
Rebecca Moss
6 papers
Ashley Matusz-Fisher
5 papers · 2 as a fellow
Janice Mehnert
5 papers
Norman Wolmark
5 papers
CL
Chad Livasy
4 papers
Deborah Toppmeyer
4 papers
EP
Elizabeth Poplin
4 papers

Clinical trials

Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer
Principal investigator · Active not recruiting · Phase 2
Wake Forest University Health Sciences
2024–2027
Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer
Principal investigator · Completed · Phase 2
Wake Forest University Health Sciences
2017–2022
Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer
Principal investigator · Active not recruiting · Phase 2
Wake Forest University Health Sciences
2016–2028
Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
Principal investigator · Completed · Phase 1, Phase 2
Rutgers, The State University of New Jersey
2008–2023